Delivery Order SPE2DR25D2206-SPE2DR26F9ML5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on June 2, 2025, with completion expected by June 24, 2025. This competitive delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside contract has a ceiling value of $1,460.13 and is scheduled for completion by January 2, 2026. The order is priced on a firm fixed-price basis and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $4,380.39 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 MG tablets (30-count units) under a firm fixed-price contract. The award, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, represents a non-competitive delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on October 20, 2025, for ORGOVYX 120 mg tablets in quantities of 30 units. The contract is valued at $1,460.13 with a firm fixed price structure and an ultimate completion date of November 10, 2025. This delivery order was issued under no set-aside provision, demonstrating the contractor's ability to compete in open federal procurement....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of ORGOVYX 120 MG tablets (30-count units) with a ceiling value of $1,460.13. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 11, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units, with a contract ceiling value of $2,771.04. The award represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025. This contract was competitively awarded without set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count units) on January 16, 2026, with an ultimate completion date of February 9, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,385.52 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, awarded on July 18, 2025, with an ultimate completion date of August 8, 2025, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-competitive award issued under an existing vehicle without set-aside provisions....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of ORGOVYX 120 mg tablets in quantities of 30 units. This competitive, non-set-aside award carries a ceiling value of $4,156.56 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 20, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 19, 2025, by the Defense Logistics Agency (DLA) to supply ORGOVYX 120 MG tablets in quantities of 30 units. The contract is valued at $1,385.52 with a firm fixed price structure and does not utilize a set-aside designation. Performance is scheduled for completion by September 10, 2025, and will be fulfilled at the awardee's Conshohocken, Pennsylvania...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9ML5Delivery Order
AmerisourceBergen Drug Corp received a delivery order valued at $4,380.39 from the Defense Logistics Agency (DLA) on January 22, 2026, for the supply of ORGOVYX 120 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of February 12, 2026, and was competitively awarded with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued up to $999.99 million through December 2031. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical supplier to federal medical procurement programs, serves military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. The DLA, operating under the Department of Defense, utilizes pharmaceutical supply contracts like this delivery order to ensure consistent availability of essential medications for military treatment facilities and related federal healthcare institutions. The company's competitive selection and firm fixed-price structure demonstrate its capability to meet federal procurement requirements for specialized pharmaceutical products on an open and competitive basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 1/21/26 |